Magdalena Sips

1.3k total citations
17 papers, 444 citations indexed

About

Magdalena Sips is a scholar working on Immunology, Radiology, Nuclear Medicine and Imaging and Virology. According to data from OpenAlex, Magdalena Sips has authored 17 papers receiving a total of 444 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Immunology, 8 papers in Radiology, Nuclear Medicine and Imaging and 6 papers in Virology. Recurrent topics in Magdalena Sips's work include Monoclonal and Polyclonal Antibodies Research (8 papers), Immune Cell Function and Interaction (7 papers) and HIV Research and Treatment (6 papers). Magdalena Sips is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (8 papers), Immune Cell Function and Interaction (7 papers) and HIV Research and Treatment (6 papers). Magdalena Sips collaborates with scholars based in United States, Belgium and Germany. Magdalena Sips's co-authors include Galit Alter, Christoph T. Berger, Musie Ghebremichael, J. Christopher Love, Yvonne J. Yamanaka, Margaret E. Ackerman, Gaia Sciaranghella, Thomas Diefenbach, Douglas S. Kwon and Peter Brouckaert and has published in prestigious journals such as Nature Communications, Frontiers in Immunology and Journal of Investigative Dermatology.

In The Last Decade

Magdalena Sips

16 papers receiving 438 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Magdalena Sips United States 11 245 147 110 92 58 17 444
Wentao Zhang China 12 260 1.1× 213 1.4× 38 0.3× 189 2.1× 148 2.6× 33 685
Sarah R. DiNapoli United States 11 311 1.3× 167 1.1× 55 0.5× 156 1.7× 110 1.9× 13 560
Andreas Hüser Germany 9 91 0.4× 63 0.4× 45 0.4× 323 3.5× 103 1.8× 11 563
Thomas Liechti United States 12 206 0.8× 32 0.2× 33 0.3× 145 1.6× 59 1.0× 22 363
Jocelyn P. Diveley United States 7 268 1.1× 42 0.3× 134 1.2× 48 0.5× 29 0.5× 9 398
Miles Smith United States 10 125 0.5× 118 0.8× 34 0.3× 152 1.7× 86 1.5× 16 377
Kellie N. Smith United States 15 352 1.4× 67 0.5× 51 0.5× 206 2.2× 77 1.3× 42 756
Jim Freeth United States 9 213 0.9× 31 0.2× 69 0.6× 170 1.8× 37 0.6× 10 606
Hong He United States 11 238 1.0× 34 0.2× 46 0.4× 101 1.1× 91 1.6× 31 497
Kevin Larimore United States 7 294 1.2× 50 0.3× 107 1.0× 90 1.0× 39 0.7× 7 415

Countries citing papers authored by Magdalena Sips

Since Specialization
Citations

This map shows the geographic impact of Magdalena Sips's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Magdalena Sips with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Magdalena Sips more than expected).

Fields of papers citing papers by Magdalena Sips

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Magdalena Sips. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Magdalena Sips. The network helps show where Magdalena Sips may publish in the future.

Co-authorship network of co-authors of Magdalena Sips

This figure shows the co-authorship network connecting the top 25 collaborators of Magdalena Sips. A scholar is included among the top collaborators of Magdalena Sips based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Magdalena Sips. Magdalena Sips is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Bao, Lei, Bethany E. Perez White, Peter Verheesen, et al.. (2024). Neonatal Fc Receptor Inhibition Reduces Bullous Pemphigoid Anti–Basement Membrane Zone IgG Deposition and Blistering in 3-Dimensional Human Skin Equivalents. Journal of Investigative Dermatology. 144(12). 2809–2812.e2. 4 indexed citations
2.
Zakrzewicz, Anna, et al.. (2024). Binding to the neonatal Fc receptor enhances the pathogenicity of anti-desmoglein-3 antibodies in keratinocytes. Frontiers in Immunology. 15. 1473637–1473637.
3.
Ostrovskaya, Olga, et al.. (2023). Efgartigimod: Clinical Development of a Novel FcRn Antagonist in the Treatment of Autoimmune Diseases. SKIN The Journal of Cutaneous Medicine. 7(2). s193–s193. 1 indexed citations
4.
Brinkhaus, Maximilian, Arthur E. H. Bentlage, Ninotska I. L. Derksen, et al.. (2022). The Fab region of IgG impairs the internalization pathway of FcRn upon Fc engagement. Nature Communications. 13(1). 6073–6073. 27 indexed citations
5.
Maho‐Vaillant, Maud, Magdalena Sips, Marie-Laure Golinski, et al.. (2022). FcRn Antagonism Leads to a Decrease of Desmoglein-Specific B Cells: Secondary Analysis of a Phase 2 Study of Efgartigimod in Pemphigus Vulgaris and Pemphigus Foliaceus. Frontiers in Immunology. 13. 863095–863095. 26 indexed citations
6.
Sips, Magdalena, Sarah Gerlo, Esteban A. Gómez, et al.. (2022). Distinct immune profiles of HIV‐infected subjects are linked to specific lipid mediator signature. Immunity Inflammation and Disease. 10(6). e629–e629. 2 indexed citations
7.
Guptill, Jeffrey T., John W. Sleasman, Magdalena Sips, et al.. (2022). Effect of FcRn antagonism on protective antibodies and to vaccines in IgG-mediated autoimmune diseases pemphigus and generalised myasthenia gravis. Autoimmunity. 55(8). 620–631. 22 indexed citations
8.
Trypsteen, Wim, Eva Malatinková, Ward De Spiegelaere, et al.. (2019). Early treated HIV-1 positive individuals demonstrate similar restriction factor expression profile as long-term non-progressors. EBioMedicine. 41. 443–454. 9 indexed citations
9.
Sips, Magdalena, et al.. (2017). Fight fire with fire: Gene therapy strategies to cure HIV. Expert Review of Anti-infective Therapy. 15(8). 747–758. 14 indexed citations
10.
Sips, Magdalena, Marina Krykbaeva, Thomas Diefenbach, et al.. (2016). Fc receptor-mediated phagocytosis in tissues as a potent mechanism for preventive and therapeutic HIV vaccine strategies. Mucosal Immunology. 9(6). 1584–1595. 75 indexed citations
11.
Sips, Magdalena, Qingquan Liu, Monia Draghi, et al.. (2016). HLA-C levels impact natural killer cell subset distribution and function. Human Immunology. 77(12). 1147–1153. 18 indexed citations
12.
Veazey, Ronald S., Heather A. Pilch-Cooper, Thomas J. Hope, et al.. (2016). Prevention of SHIV transmission by topical IFN-β treatment. Mucosal Immunology. 9(6). 1528–1536. 33 indexed citations
13.
Cauwels, Anje, Benjamin Vandendriessche, Jennyfer Bultinck, et al.. (2013). TLR2 activation causes no morbidity or cardiovascular failure, despite excessive systemic nitric oxide production. Cardiovascular Research. 100(1). 28–35. 11 indexed citations
14.
Yamanaka, Yvonne J., et al.. (2012). Single-cell analysis of the dynamics and functional outcomes of interactions between human natural killer cells and target cells. Integrative Biology. 4(10). 1175–1175. 81 indexed citations
15.
Sips, Magdalena, Gaia Sciaranghella, Ning Tong, et al.. (2012). Natural Killer cells present in gut mucosa as potential ADCC effector cells. Retrovirology. 9(S2). 1 indexed citations
16.
Dugast, Anne‐Sophie, Christoph T. Berger, Margaret E. Ackerman, et al.. (2011). Decreased Fc receptor expression on innate immune cells is associated with impaired antibody-mediated cellular phagocytic activity in chronically HIV-1 infected individuals. Virology. 415(2). 160–167. 68 indexed citations
17.
Sips, Magdalena, Gaia Sciaranghella, Thomas Diefenbach, et al.. (2011). Altered distribution of mucosal NK cells during HIV infection. Mucosal Immunology. 5(1). 30–40. 52 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Wentao Zhang Breakdown of academic impact, for papers by Sarah R. DiNapoli Breakdown of academic impact, for papers by Andreas Hüser Breakdown of academic impact, for papers by Thomas Liechti Breakdown of academic impact, for papers by Jocelyn P. Diveley Breakdown of academic impact, for papers by Miles Smith Breakdown of academic impact, for papers by Kellie N. Smith Breakdown of academic impact, for papers by Jim Freeth Breakdown of academic impact, for papers by Hong He Breakdown of academic impact, for papers by Kevin Larimore
Rankless by CCL
2026